1460773563-95032046-a164-4258-818a-e9c7149c43ea

1. An acetyl-CoA producing microorganism comprising an acetyl-CoA production cycle obtained by imparting at least one enzymatic activity selected from the group consisting of malate thiokinase, malyl-CoA lyase, glyoxylate carboligase, 2-hydroxy-3-oxopropionate reductase, and hydroxypyruvate reductase, to a microorganism that does not have any of the following (a), (b), (c), (d) or (e):
(a) a carbon dioxide fixation cycle including an enzymatic reaction from malonyl-CoA to malonate semialdehyde or 3-hydroxypropionate;
(b) a carbon dioxide fixation cycle including an enzymatic reaction from acetyl-CoA and CO2 to pyruvate;
(c) a carbon dioxide fixation cycle including an enzymatic reaction from crotonyl-CoA and CO2 to ethylmalonyl-CoA or glutaconyl-CoA;
(d) a carbon dioxide fixation cycle including an enzymatic reaction from CO2 to formate; or
(e) at least one selected from the group consisting of malate thiokinase and malyl-CoA lyase,
the acetyl-CoA producing microorganism being obtained without imparting any of (a), (b), (c), or (d) to the microorganism, or such that the microorganism exhibits none of the functions of (a), (b), (c), or (d) even if one or more of (a), (b), (c), or (d) is imparted thereto,
wherein, in the microorganism: at least one enzymatic activity selected from the group consisting of pyruvate kinase, pyruvate carboxylase, phosphoenolpyruvate carboxylase, phosphoenolpyruvate carboxykinase, malate dehydrogenase, malate thiokinase, malyl-CoA lyase, glyoxylate carboligase, 2-hydroxy-3-oxopropionate reductase, hydroxypyruvate isomerase, hydroxypyruvate reductase, glycerate 2-kinase, glycerate 3-kinase, phosphoglycerate mutase, and enolase, is enhanced; at least one enzymatic activity selected from the group consisting of a malic enzyme and fumarate reductase is inactivated or reduced; or any combination thereof.
2. The acetyl-CoA producing microorganism according claim 1, wherein the acetyl-CoA producing microorganism comprises an acetyl-CoA production cycle wherein:
phosphoenolpyruvate or pyruvate is converted to oxaloacetate;
oxaloacetate is converted to 2-hydroxy-3-oxopropionate by malate thiokinase, malyl-CoA lyase, and glyoxylate carboligase;
2-hydroxy-3-oxopropionate is converted to 2-phosphoglycerate; and
2-phosphoglycerate is converted to phosphoenolpyruvate.
3. The acetyl-CoA producing microorganism according to claim 1, wherein the acetyl-CoA producing microorganism comprises an acetyl-CoA production cycle including the following (f), (g), (h), (i), (j), (k), (l) and (m):
(f) at least one selected from the group consisting of: pyruvate kinase and pyruvate carboxylase; phosphoenolpyruvate carboxylase; and phosphoenolpyruvate carboxykinase;
(g) malate dehydrogenase;
(h) malate thiokinase;
(i) malyl-CoA lyase;
(j) glyoxylate carboligase;
(k) at least one selected from the group consisting of: 2-hydroxy-3-oxopropionate reductase; and hydroxypyruvate isomerase and hydroxypyruvate reductase;
(l) at least one selected from the group consisting of: glycerate 2-kinase; and glycerate 3-kinase and phosphoglycerate mutase; and
(m) enolase.
4. The acetyl-CoA producing microorganism according to claim 1, wherein the microorganism that does not have any of (a), (b), (c), (d), or (e), is a microorganism belonging to Enterobacteriaceae or a microorganism belonging to coryneform bacteria.
5. The acetyl-CoA producing microorganism according to claim 1, wherein the microorganism that does not have any of (a), (b), (c), (d), or (e), is an Escherichia bacterium or a Pantoea bacterium belonging to Enterobacteriaceae, or is a Corynebacterium bacterium belonging to coryneform bacteria.
6. A method of producing acetyl-CoA, the method comprising: culturing the acetyl-CoA producing microorganism according to claim 1 while contacting the acetyl-CoA producing microorganism with a carbon source material, and collecting an intended product obtained by the contacting.
7. The method of producing acetyl-CoA according to claim 6, further comprising supplying at least one selected from the group consisting of a carbonate ion, a bicarbonate ion, carbon dioxide gas, and a reductant, to a culture medium used for the culturing.
8. The method of producing acetyl-CoA according to claim 6, further comprising collecting a gas that contains carbon dioxide generated by the culturing and supplying the gas to a culture medium used for the culturing.
9. A method of producing acetyl-CoA, comprising:
culturing an acetyl-CoA producing microorganism comprising an acetyl-CoA production cycle obtained by imparting at least one enzymatic activity selected from the group consisting of malate thiokinase, malyl-CoA lyase, glyoxylate carboligase, 2-hydroxy-3-oxopropionate reductase, and hydroxypyruvate reductase, to a microorganism that does not have any of the following (a), (b), (c), (d) or (e):
(a) a carbon dioxide fixation cycle including an enzymatic reaction from malonyl-CoA to malonate semialdehyde or 3-hydroxypropionate;
(b) a carbon dioxide fixation cycle including an enzymatic reaction from acetyl-CoA and CO2 to pyruvate;
(c) a carbon dioxide fixation cycle including an enzymatic reaction from crotonyl-CoA and CO2 to ethylmalonyl-CoA or glutaconyl-CoA;
(d) a carbon dioxide fixation cycle including an enzymatic reaction from CO2 to formate; or
(e) at least one selected from the group consisting of malate thiokinase and malyl-CoA lyase,
the acetyl-CoA producing microoranism being obtained without imparting any of (a), (b), (c), or (d) to the microorganism, or such that the microorganism exhibits none of the functions of (a), (b), (c), or (d) even if one or more of (a), (b), (c), or (d) is imparted thereto; and
supplying at least one selected from the group consisting of a carbonate ion or a bicarbonate ion with a total supply amount of 150 mmolL or more, carbon dioxide gas with an average bubble diameter of 100 \u03bcm or more, and sodium sulfite with a total supply amount of from 0.01 gl to 50 gL, to a culture medium used for the culturing.
10. The method of producing acetyl-CoA according to claim 9, further comprising collecting a gas that contains carbon dioxide generated by the culturing and supplying the gas to the culture medium used for the culturing.
11. The method of producing acetyl-CoA according to claim 9, wherein the acetyl-CoA producing microorganism comprises an acetyl-CoA production cycle in which phosphoenolpyruvate or pyruvate is converted to oxaloacetate, oxaloacetate is converted to 2-hydroxy-3-oxopropionate by malate thiokinase, malyl-CoA lyase, and glyoxylate carboligase, 2-hydroxy-3-oxopropionate is converted to 2-phosphoglycerate, and 2-phosphoglycerate is converted to phosphoenolpyruvate.
12. The method of producing acetyl-CoA according to claim 9, wherein the acetyl-CoA producing microorganism comprises an acetyl-CoA production cycle including the following (f), (g), (h), (i), (j), (k), (l), and (m):
(f) at least one selected from the group consisting of: pyruvate kinase and pyruvate carboxylase; phosphoenolpyruvate carboxylase; and phosphoenolpyruvate carboxykinase;
(g) malate dehydrogenase;
(h) malate thiokinase;
(i) malyl-CoA lyase;
(j) glyoxylate carboligase;
(k) at least one selected from the group consisting of: 2-hydroxy-3-oxopropionate reductase; and hydroxypyruvate isomerase and hydroxypyruvate reductase;
(l) at least one selected from the group consisting of: glycerate 2-kinase; and glycerate 3-kinase and phosphoglycerate mutase; and
(m) enolase.
13. The method of producing acetyl-CoA according to claim 9, wherein the microorganism that does not have any of (a), (b), (c), (d), or (e), is a microorganism belonging to Enterobacteriaceae or a microorganism belonging to coryneform bacteria.
14. The method of producing acetyl-CoA according to claim 9, wherein the microorganism that does not have any of (a), (b), (c), (d), or (e), is an Escherichia bacterium or a Pantoea bacterium belonging to Enterobacteriaceae, or is a Corynebacterium bacterium belonging to coryneform bacteria.
15. A method of producing isopropyl alcohol, comprising allowing the acetyl-CoA producing microorganism to produce isopropyl alcohol, using, as an ntermediate, acetyl-CoA produced by the method of producing acetyl-CoA according to claim 9.
16. A method of producing acetone, comprising allowing the acetyl-CoA producing microorganism to produce acetone, using, as an intermediate, acetyl-CoA produced by the method of producing acetyl-CoA according to claim 9.
17. A method of producing glutamic acid, comprising allowing the acetyl-CoA producing microorganism to produce glutamic acid, using, as an intermediate, acetyl-CoA produced by the method of producing acetyl-CoA according to claim 9.
18. A method of producing glutamic acid comprising: culturing the acetyl-CoA producing microorganism according to claim 1 while contacting the acetyl-CoA producing microorganism with a carbon source material, and collecting the glutamic acid obtained by the contacting.
19. A microorganism belonging to the genus Aspergillus or the genus Cupriavidus obtained by imparting at least one enzymatic activity selected from the group consisting of malate thiokinase and malyl-CoA lyase, to a microorganism that does not have any of the following (a2), (b2), (c2), (d2) or (e2):
(a2) a carbon dioxide fixation cycle including an enzymatic reaction from malonyl-CoA to malonate semialdehyde or 3-hydroxypropionate;
(b2) a carbon dioxide fixation cycle including an enzymatic reaction from acetyl-CoA and CO2 to pyruvate;
(c2) a carbon dioxide fixation cycle including an enzymatic reaction from crotonyl-CoA and CO2 to ethylmalonyl-CoA or glutaconyl-CoA;
(d2) a carbon dioxide fixation cycle including an enzymatic reaction from CO2 to formate; or
(e2) at least one selected from the group consisting of malate thiokinase and malyl-CoA lyase,
the microorganism belonging to the genus Aspergillus or the genus Cupriavidus being obtained without imparting any of (a2), (b2), (c2), or (d2) to the microorganism, or such that the microorganism exhibits none of the functions of (a2), (b2), (c2), or (d2) even if one or more of (a2), (b2), (c2), or (d2) is imparted thereto.
20. The microorganism according to claim 19, comprising an ability to produce acetyl-CoA.
21. The microorganism according to claim 19, the microorganism belonging to the genus Aspergillus or the genus Cupriavidus being obtained by further imparting at least one enzymatic activity selected from the group consisting of glyoxylate carboligase, 2-hydroxy-3-oxopropionate reductase, and hydroxypyruvate reductase.
22. The microorganism according to claim 19, comprising an acetyl-CoA production cycle wherein:
phosphoenolpyruvate or pyruvate is converted to oxaloacetate;
oxaloacetate is converted to 2-hydroxy-3-oxopropionate by malate thiokinase, malyl-CoA lyase, and glyoxylate carboligase;
2-hydroxy-3-oxopropionate is converted to 2-phosphoglycerate; and
2-phosphoglycerate is converted to phosphoenolpyruvate.
23. The microorganism according to claim 19, comprising an acetyl-CoA production cycle including the following (f2), (g2), (h2), (i2), (j2), (k2), (l2), and (m2):
(f2) at least one selected from the group consisting of: pyruvate kinase and pyruvate carboxylase; phosphoenolpyruvate carboxylase; and phosphoenolpyruvate carboxykinase;
(g2) malate dehydrogenase;
(h2) malate thiokinase;
(i2) malyl-CoA lyase;
(j2) glyoxylate carboligase;
(k2) at least one selected from the group consisting of: 2-hydroxy-3-oxopropionate reductase; and hydroxypyruvate isomerase and hydroxypyruvate reductase;
(l2) at least one selected from the group consisting of: glycerate 2-kinase; and glycerate 3-kinase and phosphoglycerate mutase; and
(m2) enolase.
24. The microorganism according to claim 19, comprising a cycle including:
at least one enzymatic reaction selected from the group consisting of the following (a3) and (b3);
the following enzymatic reactions (c3), (d3), (e3), (f3), and (g3); and
at least one selected from the group consisting of the following enzymatic reaction (h3), the following enzymatic reactions (i3), (j3), (k3) and (n3), and the following enzymatic reactions (i3), (j3), (l3), (m3) and (n3):
(a3) an enzymatic reaction from phosphoenolpyruvate to oxaloacetate;
(b3) an enzymatic reaction from pyruvate to oxaloacetate;
(c3) an enzymatic reaction from oxaloacetate to malate;
(d3) an enzymatic reaction from malate to malyl-CoA;
(e3) an enzymatic reaction from malyl-CoA to glyoxylate and acetyl-CoA;
(f3) an enzymatic reaction from glyoxylate to glycine;
(g3) an enzymatic reaction from glycine to serine;
(h3) an enzymatic reaction from serine to pyruvate;
(i3) an enzymatic reaction from serine to 3-hydroxypyruvate;
(j3) an enzymatic reaction from 3-hydroxypyruvate to glycerate;
(k3) an enzymatic reaction from glycerate to 2-phosphoglycerate;
(l3) an enzymatic reaction from glycerate to 3-phosphoglycerate;
(m3) an enzymatic reaction from 3-phosphoglycerate to 2-phosphoglycerate; and
(n3) an enzymatic reaction from 2-phosphoglycerate to phosphoenolpyruvate.
25. The microorganism according to claim 19, comprising:
at least one enzyme selected from the group consisting of the following (a4) and (b4);
the following enzymes (c4), (d4), (e4), (f4), and (g4); and
at least one selected from the group consisting of the following enzyme (h4), the following enzymes (i4), (j4), (k4), and (n4), and the following enzymes (i4), (j4), (l4), (m4) and (n4):
(a4) at least one selected from the group consisting of pyruvate kinase and pyruvate carboxylase; phosphoenolpyruvate carboxylase; and phosphoenolpyruvate carboxykinase;
(b4) pyruvate carboxylase;
(c4) malate dehydrogenase;
(d4) malate thiokinase;
(e4) malyl-CoA lyase;
(f4) glycine transaminase;
(g4) a glycine cleavage system and serine hydroxymethyltransferase;
(h4) serine dehydratase;
(i4) serine transaminase;
(j4) hydroxypyruvate reductase;
(k4) glycerate 2-kinase;
(l4) glycerate 3-kinase;
(m4) phosphoglycerate mutase; and
(n4) enolase.
26. The microorganism according to claim 19, wherein the microorganism that does not have any of (a2), (b2), (c2), (d2), or (e2) is Aspergillus niger, Aspergillus terreus, or Cupriavidus necator.
27. A method of producing acetyl-CoA comprising: culturing the microorganism according to claim 19 while contacting the microorganism with a carbon source material, and collecting an intended product obtained by the contacting.
28. The method of producing acetyl-CoA according to claim 27, further comprising supplying at least one selected from the group consisting of a carbonate ion, a bicarbonate ion, carbon dioxide gas, and a reductant, to a culture medium used for the culturing.
29. The method of producing acetyl-CoA according to claim 27, further comprising collecting a gas that contains carbon dioxide generated by the culturing and supplying the gas to a culture medium used for the culturing.
30. A method of producing citric acid, comprising producing citric acid from a carbon source material using the microorganism according to claim 19.
31. A method of producing itaconic acid, comprising producing itaconic acid from a carbon source material using the microorganism according to claim 19.
32. A method of producing (poly)3-hydroxybutyric acid, comprising producing (poly)3-hydroxybutyric acid from a carbon source material using the microorganism according to claim 19.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A therapeutic peptide comprising at least one core sequence comprising at least five amino acid residues, the core sequence selected from the group consisting of:
Xm\u2014N\u2014Xn\u2014S\u2014Xp;
Xm-Q-Xn\u2014S\u2014Xp;
Xm\u2014N\u2014Xn-T-Xp; and
Xm-Q-Xn-T-Xp,
wherein N is asparagine, Q is glutamine, S is serine, T is threonine, X is a naturally occurring L amino acid, and m, n, and p are integers greater than or equal to zero, and fragments or derivatives thereof.
2. The peptide of claim 1, wherein the peptide comprises 4 to 8 amino acids and the sum of the integers m, n, and p is within the range of 2 to 6.
3. The peptide of claim 1, wherein the peptide is selected from the group consisting of WNSTL (SEQ ID NO:1), NQHTPR (SEQ ID NO:2), WNSTY (SEQ ID NO:5), YNSTL (SEQ ID NO:6), YQPSL (SEQ ID NO:7), VQATQS (SEQ ID NO:8) and fragments or derivatives thereof.
4. A pro-angiogenic peptide comprising at least one core sequence according to claim 1.
5. A pro-angiogenic composition comprising at least one peptide according to claim 1.
6. The composition of claim 5, wherein the composition comprises at least one construct comprising the at least one peptide.
7. The composition of claim 6, wherein the at least one construct comprises one to four peptides.
8. The composition of claim 6, wherein the at least one construct comprises at least one linker having at least one of variable length and composition.
9. The composition of claim 6, wherein the at least one construct is branched.
10. A treatment method comprising administering an effective dose of the composition of claim 5 to a subject.
11. The method of claim 10, wherein the treatment is achieved without causing a deleterious side effect.
12. The method of claim 11, wherein the treatment is achieved without causing a side effect comprising deleterious inflammation.
13. A treatment method according to claim 10 for treating at least one medical condition, wherein the condition comprises at least one type of wound.
14. The method of claim 10, wherein administering the composition stimulates the production of at least one therapeutically beneficial cytokine.
15. The method of claim 14, wherein the at least one cytokine is PDGF-BB.
16. The method of claim 10, wherein administrating the composition inhibits the production of at least one therapeutically deleterious cytokine.
17. The method of claim 16, wherein the at least one cytokine is IL-8.
18. A treatment method according to claim 10, the method comprising at least one of:
regulating the release of a specific pattern of cytokine molecules in a subject; and
modulating the immune system of the subject,

thereby promoting the process of wound healing.
19. The method of claim 18, wherein modulating the immune system of the subject comprises stimulating the activity of phagocytic cells
20. The treatment method of claim 10, wherein the composition is administered to the subject by at least one method selected from the group consisting of injection, topically and orally.
21. The treatment method of claim 10, wherein the composition further comprises a pharmaceutically acceptable carrier.
22. A method for stimulating angiogenesis in a subject, comprising administering to a subject an effective amount of a composition according to claim 10.
23. The treatment method of claim 10, wherein the composition administered is adjacent to at least one surface of an object or body.
24. The treatment method of claim 10, wherein the at least one surface comprises at least one of a bioactive surface and an inert, non-biological surface.
25. A medical device comprising at least one surface according to claim 23.